Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation

Liver Transplantation

Volumn 13, Issue 3, 2007, Pages 367-373

  Rosenau, Jens ^a   Hooman, Nazanin ^a   Hadem, Johannes ^a   Rifai, Kinan ^a   Bahr, Matthias ^a   Phillipp, Gunnar ^b   Tillmann, Hans L ^c   Klempnauer, Juergen ^a   Strassburg, Christian P ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ZLB Behring GmbH   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADJUVANT; CYCLOSPORIN; HEPATECT CP; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; RECOMBINANT HEPATITIS B VACCINE; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMORAL IMMUNITY; INFECTION PREVENTION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REINFECTION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33947401529     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21003     Document Type: Article

References (29)

1. Todo S. Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991;13:619-626.
2. Eason JD. Freeman RB Jr, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, Cosimi AB. Should liver transplantation be performed for patients with hepatitis B? Transplantation 1994;57:1588-1593.
3. Muller R, Gubernatis G, Farle M, Niehoff G, Klein H. Wittekind C, et al. Liver transplantation to HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991;13:90-96.
4. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-l847.
5. Perrillo RP, Mason AL. Hepatitis B and liver transplantation Problems and promises. N Engl J Med 1993;329: 1885-1887.
6. Lok AS. Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl 2002;8(Suppl):S67-73.
7. Samuel D. Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there. J Hepatol 2001;34:943-945.
8. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28:585-589.
9. Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl 2002;8:2-9.
10. Rosenau J. Bahr MJ, Tillmann HL, Trautwein C. Klempnauer J, Manns MP, Boker KHW. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection. J Hepatol 2001;34;895-902.
11. Bienzle U, Gunther M, Neuhaus R, Vandepapeliere P, Vollmar J, Lun A, Neuhaus P. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003;38:811-819.
12. Sanchez-Fueyo A, Rimola A. Grande L, Costa J, Mas A, Navasa M. et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000;31:496-501.
13. Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, et al. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002;35:176-181.
14. Albeniz Arbizu E. Barcena Marugan R, Oton Nieto E, Carrera Alonzo E, Garcia Gonzalez M, Moreno Garcia J, et al. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results. Transplant Proc 2003;35:1848-1849.
15. Lo CM, Liu CL, Chan SC. Lau GK, Fan ST. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol 2005;43:283-287.
16. Sanchez-Fueyo A, Martinez-Bauer E. Rimola A. Hepatitis B vaccination after liver transplantation. Hepatology 2002;36:257-258; discussion 258-259.
17. Rosenau J, Hooman N, Rifai K, Solga T, Tillmann HL, Grzegowski E, et al. Active immunization after liver transplantation for HBV related liver disease: failure to induce HBV specific humoral and cellular immune responses [abstract]. J Hepatol 2004;40:6.
18. Starkel P, Stoffel M, Lerut J, Horsmans Y. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients. Liver Transpl 2005;11:1228-1234.
19. Wen YM, Qu D. Zhou SH. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Int Rev Immunol 1999;18:251-258.
20. McCluskie MJ, Wen YM, Di Q, Davis HL. Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes. Viral Immunol 1998;11;245-252
21. Chalasani N, Smallwood G, Halcomb J, Fried MW, Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg 1998;4:128-132.
22. Wagner D. Wagenbreth I, Stachan-Kunstyr R, Thoma HA, Hemmerling AE, Flik J. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2 and S gene products. Clin Investig 1994;72:350-352.
23. Loinaz C, de Juanes JR, Gonzalez EM, Lopez A, Lumbreras C, Gomez R, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44:235-238.
24. Rentenaar RJ, van Diepen FN, Meijer RT, Surachno S, Wilmink JM, Schellekens PT, et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 2002;62:319-328.
25. Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13:160-164.
26. Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001;33:963-971.
27. Boni C, Penna A, Bertoletti A, Lamonaca V. Rapti I, Missale G, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 2003;39:595-605.
28. Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF. Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B. J Med Virol 2002;66: 452-460.
29. O'Hagan DT, MacKichan ML, Singh M. Recent developments in adjuvants for vaccine against infectious diseases. Biomol Eng 2001;18:69-85.